| Mr Brett Alan Cooley, CRNA | |
|
4150 Nelson Rd, A4 Anesthesia Associates, Lake Charles, LA 70605 | |
| (337) 474-6353 | |
| (337) 477-7616 |
| Full Name | Mr Brett Alan Cooley |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 31 Years |
| Location | 4150 Nelson Rd, Lake Charles, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154463925 | NPI | - | NPPES |
| 1651494 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | AP01717 (Louisiana) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | RN065292 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lake Charles Memorial Hospital | Lake charles, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lcms Cardiovascular Diseases, Llc | 1951541515 | 27 |
| Youngs Professional Services Llc | 2163524992 | 239 |
News Archive
Doctors at present lack a test that can distinguish fast-developing tumours that need urgent attention from slow-growing ones that are not a threat and need only watching, and as a result many men have operations that can leave them impotent and incontinent for prostate tumours that would never have killed them.
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation long enough to respond to and stop virus infection.
Virtual reality isn't just for gaming. Researchers can use virtual reality, or VR, to assess participants' attention, memory and problem-solving abilities in real world settings.
University of Manchester scientists have led an international team to discover new treatments for a rare and potentially lethal childhood disease that is the clinical opposite of diabetes mellitus.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
› Verified 8 days ago
| Entity Name | Anesthesiology Group Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255399598 PECOS PAC ID: 0042110298 Enrollment ID: O20040113000117 |
News Archive
Doctors at present lack a test that can distinguish fast-developing tumours that need urgent attention from slow-growing ones that are not a threat and need only watching, and as a result many men have operations that can leave them impotent and incontinent for prostate tumours that would never have killed them.
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation long enough to respond to and stop virus infection.
Virtual reality isn't just for gaming. Researchers can use virtual reality, or VR, to assess participants' attention, memory and problem-solving abilities in real world settings.
University of Manchester scientists have led an international team to discover new treatments for a rare and potentially lethal childhood disease that is the clinical opposite of diabetes mellitus.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
› Verified 8 days ago
| Entity Name | Youngs Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922178599 PECOS PAC ID: 2163524992 Enrollment ID: O20070226000608 |
News Archive
Doctors at present lack a test that can distinguish fast-developing tumours that need urgent attention from slow-growing ones that are not a threat and need only watching, and as a result many men have operations that can leave them impotent and incontinent for prostate tumours that would never have killed them.
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation long enough to respond to and stop virus infection.
Virtual reality isn't just for gaming. Researchers can use virtual reality, or VR, to assess participants' attention, memory and problem-solving abilities in real world settings.
University of Manchester scientists have led an international team to discover new treatments for a rare and potentially lethal childhood disease that is the clinical opposite of diabetes mellitus.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
› Verified 8 days ago
| Entity Name | Lcms Cardiovascular Diseases, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285869370 PECOS PAC ID: 1951541515 Enrollment ID: O20130703000206 |
News Archive
Doctors at present lack a test that can distinguish fast-developing tumours that need urgent attention from slow-growing ones that are not a threat and need only watching, and as a result many men have operations that can leave them impotent and incontinent for prostate tumours that would never have killed them.
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation long enough to respond to and stop virus infection.
Virtual reality isn't just for gaming. Researchers can use virtual reality, or VR, to assess participants' attention, memory and problem-solving abilities in real world settings.
University of Manchester scientists have led an international team to discover new treatments for a rare and potentially lethal childhood disease that is the clinical opposite of diabetes mellitus.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Brett Alan Cooley, CRNA Po Box 122431, Dept 2431, Dallas, TX 75312-2431 Ph: (337) 480-8900 | Mr Brett Alan Cooley, CRNA 4150 Nelson Rd, A4 Anesthesia Associates, Lake Charles, LA 70605 Ph: (337) 474-6353 |
News Archive
Doctors at present lack a test that can distinguish fast-developing tumours that need urgent attention from slow-growing ones that are not a threat and need only watching, and as a result many men have operations that can leave them impotent and incontinent for prostate tumours that would never have killed them.
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation long enough to respond to and stop virus infection.
Virtual reality isn't just for gaming. Researchers can use virtual reality, or VR, to assess participants' attention, memory and problem-solving abilities in real world settings.
University of Manchester scientists have led an international team to discover new treatments for a rare and potentially lethal childhood disease that is the clinical opposite of diabetes mellitus.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
› Verified 8 days ago
Mr. Leslie B Free, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4150 Nelson Road, A-4, Lake Charles, LA 70605 Phone: 337-478-2124 Fax: 337-477-7616 | |
Mr. Michael Shelton Adams, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1000 Walters St, Lsu W O Moss Regional Medical Center, Lake Charles, LA 70607 Phone: 337-475-8333 | |
Mr. Robert Geise Phillips, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4150 Nelson Rd, A4 Anesthesia Associates, Lake Charles, LA 70605 Phone: 337-474-6353 Fax: 337-477-7616 | |
Jordan Daughenbaugh, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1900 W Gauthier Rd, Lake Charles, LA 70605 Phone: 337-480-7000 | |
Mr. Randall Dale Biggs, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4150 Nelson Rd, A4 Anesthesia Associates, Lake Charles, LA 70605 Phone: 337-474-6353 Fax: 337-477-7616 | |
Carl G Mallett, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1128 Hidden Oak Ln, Lake Charles, LA 70605 Phone: 337-478-1085 | |
Nathaniel J Dennis, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 424 W Mcneese St, Suite L, Lake Charles, LA 70605 Phone: 337-478-0511 Fax: 337-478-5644 |